Jie Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jie Sun has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Chun Yuan
Department of Radiology, University of Washington, Seattle, WA, USA
10 shared publications Daniel S. Hippe
Clinical Research Division, Fred Hutchinson Cancer Research Center, United States
9 shared publications- Niranjan Balu
Department of Radiology, University of Washington, Seattle, WA, USA
9 shared publications - Thomas S. Hatsukami
Department of Surgery, University of Washington, Seattle, USA
8 shared publications - Daniel Scott Hippe
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
7 shared publications Chun Yuan
Department of Radiology, University of Washington, 850 Republican St, Seattle, WA 98109, United States; Department of Bioengineering, University of Washington, United States
6 shared publications
Latest Publications
- 19 August 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (10) , 106719
Characterization of non-stenotic plaques in intracranial arteries with multi-contrast, multi-planar vessel wall image analysis
- 19 August 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (10) , 106719
Characterization of non-stenotic plaques in intracranial arteries with multi-contrast, multi-planar vessel wall image analysis
- 1 April 2022
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (4) , 504-513
Elevated Hemoglobin A1c Is Associated With Leaky Plaque Neovasculature as Detected by Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Background: Patients with diabetes have accelerated atherosclerosis progression, but the underlying mechanisms are not fully understood. Dynamic contrast-enhanced magnetic resonance imaging has allowed in vivo characterization of plaque neovasculature, which plays a critical role in plaque progression. We aimed to evaluate the impact of diabetes on carotid plaque neovasculature as assessed by dynamic contrast-enhanced magnetic resonance imaging. Methods: Patients with recent ischemic stroke and ipsilateral carotid plaque underwent multicontrast magnetic resonance imaging for characterizing plaque morphology and dynamic contrast-enhanced magnetic resonance imaging for pharmacokinetic parameters of plaque neovasculature, including transfer constant ( K trans , reflecting flow, endothelial surface area, and permeability) and fractional plasma volume ( ν p ). Results: Sixty-five patients were enrolled, including 30 patients with diabetes (years since diagnosis: median 5.0 [interquartile range, [3.0–12.0]) and 35 patients without diabetes. Subjects with diabetes had a greater plaque burden and a higher prevalence of high-risk characteristics. Additionally, carotid plaques in the subjects with diabetes showed higher K trans than those in the subjects without diabetes (0.100±0.048 min -1 versus 0.067±0.042 min -1 , P =0.005) but ν p was numerically lower in the subjects with diabetes (5.2±3.7% versus 6.2±4.3%, P =0.31). The association of diabetes with high K trans (β=0.033, P =0.005) was independent of patient and plaque characteristics and remained largely intact after adjusting for serum lipids, glucose, or hs-CRP (high-sensitivity C-reactive protein). However, it became nonexistent after adjusting for hemoglobin A1c (β=−0.010, P =0.49). Conclusions: Dynamic contrast-enhanced magnetic resonance imaging of carotid plaques suggested that plaque neovasculature in patients with diabetes is leaky, indicating enhanced capability of bringing blood constituents and facilitating extravasation of inflammatory cells, erythrocytes, and plasma proteins. Leaky plaque neovasculature correlated with hemoglobin A1c and may play a role in accelerated atherosclerosis progression in diabetes.
- 1 April 2022
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (4) , 504-513
Elevated Hemoglobin A1c Is Associated With Leaky Plaque Neovasculature as Detected by Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Background: Patients with diabetes have accelerated atherosclerosis progression, but the underlying mechanisms are not fully understood. Dynamic contrast-enhanced magnetic resonance imaging has allowed in vivo characterization of plaque neovasculature, which plays a critical role in plaque progression. We aimed to evaluate the impact of diabetes on carotid plaque neovasculature as assessed by dynamic contrast-enhanced magnetic resonance imaging. Methods: Patients with recent ischemic stroke and ipsilateral carotid plaque underwent multicontrast magnetic resonance imaging for characterizing plaque morphology and dynamic contrast-enhanced magnetic resonance imaging for pharmacokinetic parameters of plaque neovasculature, including transfer constant ( K trans , reflecting flow, endothelial surface area, and permeability) and fractional plasma volume ( ν p ). Results: Sixty-five patients were enrolled, including 30 patients with diabetes (years since diagnosis: median 5.0 [interquartile range, [3.0–12.0]) and 35 patients without diabetes. Subjects with diabetes had a greater plaque burden and a higher prevalence of high-risk characteristics. Additionally, carotid plaques in the subjects with diabetes showed higher K trans than those in the subjects without diabetes (0.100±0.048 min -1 versus 0.067±0.042 min -1 , P =0.005) but ν p was numerically lower in the subjects with diabetes (5.2±3.7% versus 6.2±4.3%, P =0.31). The association of diabetes with high K trans (β=0.033, P =0.005) was independent of patient and plaque characteristics and remained largely intact after adjusting for serum lipids, glucose, or hs-CRP (high-sensitivity C-reactive protein). However, it became nonexistent after adjusting for hemoglobin A1c (β=−0.010, P =0.49). Conclusions: Dynamic contrast-enhanced magnetic resonance imaging of carotid plaques suggested that plaque neovasculature in patients with diabetes is leaky, indicating enhanced capability of bringing blood constituents and facilitating extravasation of inflammatory cells, erythrocytes, and plasma proteins. Leaky plaque neovasculature correlated with hemoglobin A1c and may play a role in accelerated atherosclerosis progression in diabetes.
- Open Access
- 8 November 2021
- Published by Springer Nature in BMC Medical Imaging
- Vol. 21 (1) , 1-13
A NIM PET/CT phantom for evaluating the PET image quality of micro-lesions and the performance parameters of CT
Background: The commonly used NEMA IEC Body phantom has a number of defects, hindering its application for detecting micro-lesions and measuring the performance parameters of computed tomography (CT). This study aimed to propose a PET/CT phantom designed by National Institute of Metrology (NIM), China, which is capable of simultaneously testing the performance of PET and CT systems, and to evaluate the quality of imaging.Methods: The phantom developed in the present study, the NIM PET/CT phantom, is composed of a PET imaging module and a CT imaging module, and these modules are connected together through bolts, which can simultaneously measure the imaging performance of PET and CT systems. Hot spheres were filled with 4:1 sphere-to-background activity concentration using18F-fluorodeoxyglucose (18F-FDG), and cold spheres were filled with non-radioactive water. We compared the results of imaging obtained from the NIM PET/CT phantom and the NEMA IEC Body phantom to assess their diagnostic efficacy. In order to evaluate the generalization ability of the NIM PET/CT phantom, three different PET/CT systems were used to scan on the same scanning protocol. To evaluate the effects of image reconstruction algorithms on image quality assessment, ordered subset expectation maximization (OSEM), OSEM-point-spread function (PSF), OSEM-TOF, and OSEM-PSF-TOF algorithms were employed.Results: The imaging quality of the NIM PET/CT phantom and the NEMA IEC Body phantom was relatively consistent. The NIM PET/CT phantom could detect 7 mm spheres without influencing the imaging quality. It was found that PSF reconstruction exhibited to reduce the speed of convergence, the contrast and background variability of spheres (13–28 mm) were significantly improved after two iterations. In addition to improve the image contrast and background variability, TOF could markedly improve the overall image quality and instrument detection limit. TOF-PSF could noticeably reduce noise level, enhance imaging details, and improve quality of imaging.Conclusions: The results showed that in comparison with the NEMA IEC Body phantom, the NIM PET/CT phantom outperformed in evaluating the PET image quality of micro-lesions and the performance parameters of CT.
- 8 November 2021
- Published by Springer Nature in BMC Medical Imaging
- Vol. 21 (1) , 1-13
Open AccessA NIM PET/CT phantom for evaluating the PET image quality of micro-lesions and the performance parameters of CT
Background: The commonly used NEMA IEC Body phantom has a number of defects, hindering its application for detecting micro-lesions and measuring the performance parameters of computed tomography (CT). This study aimed to propose a PET/CT phantom designed by National Institute of Metrology (NIM), China, which is capable of simultaneously testing the performance of PET and CT systems, and to evaluate the quality of imaging.Methods: The phantom developed in the present study, the NIM PET/CT phantom, is composed of a PET imaging module and a CT imaging module, and these modules are connected together through bolts, which can simultaneously measure the imaging performance of PET and CT systems. Hot spheres were filled with 4:1 sphere-to-background activity concentration using18F-fluorodeoxyglucose (18F-FDG), and cold spheres were filled with non-radioactive water. We compared the results of imaging obtained from the NIM PET/CT phantom and the NEMA IEC Body phantom to assess their diagnostic efficacy. In order to evaluate the generalization ability of the NIM PET/CT phantom, three different PET/CT systems were used to scan on the same scanning protocol. To evaluate the effects of image reconstruction algorithms on image quality assessment, ordered subset expectation maximization (OSEM), OSEM-point-spread function (PSF), OSEM-TOF, and OSEM-PSF-TOF algorithms were employed.Results: The imaging quality of the NIM PET/CT phantom and the NEMA IEC Body phantom was relatively consistent. The NIM PET/CT phantom could detect 7 mm spheres without influencing the imaging quality. It was found that PSF reconstruction exhibited to reduce the speed of convergence, the contrast and background variability of spheres (13–28 mm) were significantly improved after two iterations. In addition to improve the image contrast and background variability, TOF could markedly improve the overall image quality and instrument detection limit. TOF-PSF could noticeably reduce noise level, enhance imaging details, and improve quality of imaging.Conclusions: The results showed that in comparison with the NEMA IEC Body phantom, the NIM PET/CT phantom outperformed in evaluating the PET image quality of micro-lesions and the performance parameters of CT.
- 1 October 2021
- Published by Springer Nature in Current Cardiology Reports
- Vol. 23 (11) , 1-10
Stroke Prevention with Extracranial Carotid Artery Disease
Purpose of Review Carotid artery stenosis is a major risk factor for ischemic stroke. Although effective treatment options exist, careful assessment of benefits and risks for individual patients is needed in clinical decision-making. This article reviews contemporary treatments for carotid artery stenosis, the underlying evidence, and areas of uncertainties. Recent Findings Specific recommendations are available to guide the standard of care of carotid artery stenosis. Nonetheless, significant uncertainties are noted in patient selection for surgical treatment of asymptomatic carotid stenosis and in optimal treatment targets for pharmacological therapies. Advanced imaging has been used to predict future risk of ipsilateral stroke and clarify mechanisms of actions of pharmacological therapies, primarily in observational studies. Summary Pharmacological and surgical treatments for extracranial carotid artery stenosis continue to evolve with many relevant clinical trials completed and clinical guidelines updated in recent years. Future clinical trials to tackle the areas of uncertainties are warranted.
- 1 October 2021
- Published by Springer Nature in Current Cardiology Reports
- Vol. 23 (11) , 1-10
Stroke Prevention with Extracranial Carotid Artery Disease
Purpose of Review Carotid artery stenosis is a major risk factor for ischemic stroke. Although effective treatment options exist, careful assessment of benefits and risks for individual patients is needed in clinical decision-making. This article reviews contemporary treatments for carotid artery stenosis, the underlying evidence, and areas of uncertainties. Recent Findings Specific recommendations are available to guide the standard of care of carotid artery stenosis. Nonetheless, significant uncertainties are noted in patient selection for surgical treatment of asymptomatic carotid stenosis and in optimal treatment targets for pharmacological therapies. Advanced imaging has been used to predict future risk of ipsilateral stroke and clarify mechanisms of actions of pharmacological therapies, primarily in observational studies. Summary Pharmacological and surgical treatments for extracranial carotid artery stenosis continue to evolve with many relevant clinical trials completed and clinical guidelines updated in recent years. Future clinical trials to tackle the areas of uncertainties are warranted.
- 29 July 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (9) , 1566-1575
Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement
SUMMARY: Current guidelines for primary and secondary prevention of stroke in patients with carotid atherosclerosis are based on the quantification of the degree of stenosis and symptom status. Recent publications have demonstrated that plaque morphology and composition, independent of the degree of stenosis, are important in the risk stratification of carotid atherosclerotic disease. This finding raises the question as to whether current guidelines are adequate or if they should be updated with new evidence, including imaging for plaque phenotyping, risk stratification, and clinical decision-making in addition to the degree of stenosis. To further this discussion, this roadmap consensus article defines the limits of luminal imaging and highlights the current evidence supporting the role of plaque imaging. Furthermore, we identify gaps in current knowledge and suggest steps to generate high-quality evidence, to add relevant information to guidelines currently based on the quantification of stenosis.
- 29 July 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (9) , 1566-1575
Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement
SUMMARY: Current guidelines for primary and secondary prevention of stroke in patients with carotid atherosclerosis are based on the quantification of the degree of stenosis and symptom status. Recent publications have demonstrated that plaque morphology and composition, independent of the degree of stenosis, are important in the risk stratification of carotid atherosclerotic disease. This finding raises the question as to whether current guidelines are adequate or if they should be updated with new evidence, including imaging for plaque phenotyping, risk stratification, and clinical decision-making in addition to the degree of stenosis. To further this discussion, this roadmap consensus article defines the limits of luminal imaging and highlights the current evidence supporting the role of plaque imaging. Furthermore, we identify gaps in current knowledge and suggest steps to generate high-quality evidence, to add relevant information to guidelines currently based on the quantification of stenosis.
- 1 June 2021
- Published by Elsevier in Atherosclerosis
- Vol. 327, 31-38
Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course study
- 1 June 2021
- Published by Elsevier in Atherosclerosis
- Vol. 327, 31-38
Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course study
- Open Access
- 1 June 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (11) , e018408
Atherosclerotic Burden and Remodeling Patterns of the Popliteal Artery as Detected in the Magnetic Resonance Imaging Osteoarthritis Initiative Data Set
Background: An artificial intelligence vessel segmentation tool, Fully Automated and Robust Analysis Technique for Popliteal Artery Evaluation (FRAPPE), was used to analyze a large databank of popliteal arteries imaged through the OAI (Osteoarthritis Initiative) to study the impact of atherosclerosis risk factors on vessel dimensions and characterize remodeling patterns. Methods and Results: Magnetic resonance images from 4668 subjects contributing 9189 popliteal arteries were analyzed using FRAPPE. Age ranged from 45 to 79 years (median, 61), and 58% were women. Mean lumen diameter, mean outer wall diameter, and mean wall thickness (MWT) were measured per artery. Their median values were 5.8 mm (interquartile range, 5.2–6.5 mm), 7.3 mm (interquartile range, 6.7–8.1 mm), and 0.78 mm (interquartile range, 0.73–0.84 mm) respectively. MWT was associated with multiple cardiovascular risk factors, with age (4.2% increase in MWT per 10‐year increase in age; 95% CI, 3.9%–4.5%) and sex (8.6% higher MWT in men than women; 95% CI, 7.7%–9.3%) being predominant. On average, lumen and outer wall diameters increased with increasing MWT until the thickness was 0.92 mm for men and 0.84 mm for women. After this point, lumen diameter decreased steadily, more rapidly in men than women (−7.9% versus −6.1% per 25% increase in MWT; P <0.001), with little change in outer wall diameter. Conclusions: FRAPPE has enabled the analysis of the large OAI knee magnetic resonance imaging data set, successfully showing that popliteal atherosclerosis is predominantly associated with age and sex. The average vessel remodeling pattern consisted of an early phase of compensatory enlargement, followed by a negative remodeling, which is more pronounced in men.
- 1 June 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (11) , e018408
Open AccessAtherosclerotic Burden and Remodeling Patterns of the Popliteal Artery as Detected in the Magnetic Resonance Imaging Osteoarthritis Initiative Data Set
Background: An artificial intelligence vessel segmentation tool, Fully Automated and Robust Analysis Technique for Popliteal Artery Evaluation (FRAPPE), was used to analyze a large databank of popliteal arteries imaged through the OAI (Osteoarthritis Initiative) to study the impact of atherosclerosis risk factors on vessel dimensions and characterize remodeling patterns. Methods and Results: Magnetic resonance images from 4668 subjects contributing 9189 popliteal arteries were analyzed using FRAPPE. Age ranged from 45 to 79 years (median, 61), and 58% were women. Mean lumen diameter, mean outer wall diameter, and mean wall thickness (MWT) were measured per artery. Their median values were 5.8 mm (interquartile range, 5.2–6.5 mm), 7.3 mm (interquartile range, 6.7–8.1 mm), and 0.78 mm (interquartile range, 0.73–0.84 mm) respectively. MWT was associated with multiple cardiovascular risk factors, with age (4.2% increase in MWT per 10‐year increase in age; 95% CI, 3.9%–4.5%) and sex (8.6% higher MWT in men than women; 95% CI, 7.7%–9.3%) being predominant. On average, lumen and outer wall diameters increased with increasing MWT until the thickness was 0.92 mm for men and 0.84 mm for women. After this point, lumen diameter decreased steadily, more rapidly in men than women (−7.9% versus −6.1% per 25% increase in MWT; P <0.001), with little change in outer wall diameter. Conclusions: FRAPPE has enabled the analysis of the large OAI knee magnetic resonance imaging data set, successfully showing that popliteal atherosclerosis is predominantly associated with age and sex. The average vessel remodeling pattern consisted of an early phase of compensatory enlargement, followed by a negative remodeling, which is more pronounced in men.
- 3 January 2021
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 37 (4) , 1415-1422
Serial magnetic resonance imaging detects a rapid reduction in plaque lipid content under PCSK9 inhibition with alirocumab
PCSK9 inhibitors lower low-density lipoprotein cholesterol (LDL-C) and reduce cardiovascular events. The clinical benefits presumably result from favorable effects on atherosclerotic plaques. Lipid-core and plaque inflammation have been recognized as main determinants of risk for plaque rupture and cardiovascular events. Both can be noninvasively assessed with carotid MRI. We studied if PCSK9 inhibition with alirocumab induces regression in lipid-core or plaque inflammation within 6 months as measured by MRI. Patients with non-calcified carotid plaque(s) and baseline LDL-C ≥ 70 mg/dl, who were statin-intolerant or taking a low-dose statin (≤ 10 mg per day of atorvastatin or an equivalent), received subcutaneous alirocumab 150 mg every 2 weeks. Carotid MRI was performed at baseline and 6 months after treatment, including pre- and post-contrast images for measuring percent lipid-core volume (%LC) and dynamic contrast-enhanced images for measuring microvessel leakiness (Ktrans), a marker of inflammation. Twenty-eight patients completed the study (69 ± 9 years; 64% male). Alirocumab led to significant changes in LDL-C (p < 0.001) and high-density lipoprotein cholesterol (HDL-C) (p = 0.003). At 6 months, there was a significant reduction in %LC (mean: − 2.1% [− 3.5, − 0.7], p = 0.005; a 17% reduction from baseline of 9.9%) without significant changes in lumen/wall area or in the inflammatory index Ktrans. Carotid plaque lipid content was reduced by 17% after 6 months of PCSK9 inhibition with alirocumab. This was seen before observable changes in lumen or wall areas, which supports pursing plaque lipid content as a more sensitive marker of therapeutic response compared to lumen or wall areas in future technical developments and serial studies.
- 3 January 2021
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 37 (4) , 1415-1422
Serial magnetic resonance imaging detects a rapid reduction in plaque lipid content under PCSK9 inhibition with alirocumab
PCSK9 inhibitors lower low-density lipoprotein cholesterol (LDL-C) and reduce cardiovascular events. The clinical benefits presumably result from favorable effects on atherosclerotic plaques. Lipid-core and plaque inflammation have been recognized as main determinants of risk for plaque rupture and cardiovascular events. Both can be noninvasively assessed with carotid MRI. We studied if PCSK9 inhibition with alirocumab induces regression in lipid-core or plaque inflammation within 6 months as measured by MRI. Patients with non-calcified carotid plaque(s) and baseline LDL-C ≥ 70 mg/dl, who were statin-intolerant or taking a low-dose statin (≤ 10 mg per day of atorvastatin or an equivalent), received subcutaneous alirocumab 150 mg every 2 weeks. Carotid MRI was performed at baseline and 6 months after treatment, including pre- and post-contrast images for measuring percent lipid-core volume (%LC) and dynamic contrast-enhanced images for measuring microvessel leakiness (Ktrans), a marker of inflammation. Twenty-eight patients completed the study (69 ± 9 years; 64% male). Alirocumab led to significant changes in LDL-C (p < 0.001) and high-density lipoprotein cholesterol (HDL-C) (p = 0.003). At 6 months, there was a significant reduction in %LC (mean: − 2.1% [− 3.5, − 0.7], p = 0.005; a 17% reduction from baseline of 9.9%) without significant changes in lumen/wall area or in the inflammatory index Ktrans. Carotid plaque lipid content was reduced by 17% after 6 months of PCSK9 inhibition with alirocumab. This was seen before observable changes in lumen or wall areas, which supports pursing plaque lipid content as a more sensitive marker of therapeutic response compared to lumen or wall areas in future technical developments and serial studies.
- Open Access
- 1 January 2021
- Published by Termedia Sp. z.o.o. in Folia Neuropathologica
- Vol. 59 (4) , 372-377
The value of high-resolution MRI in the diagnosis, efficacy of treatment, and prognosis of central nervous system vasculitis
Aim of the study To explore the high-resolution magnetic resonance imaging (HR-MRI) characteristics of central nervous system (CNS) vasculitis and to explore the value of HR-MRI in the treatment effect and prognosis evaluation of CNS vasculitis. Material and methods During the follow-up of...
- 1 January 2021
- Published by Termedia Sp. z.o.o. in Folia Neuropathologica
- Vol. 59 (4) , 372-377
Open AccessThe value of high-resolution MRI in the diagnosis, efficacy of treatment, and prognosis of central nervous system vasculitis
Aim of the study To explore the high-resolution magnetic resonance imaging (HR-MRI) characteristics of central nervous system (CNS) vasculitis and to explore the value of HR-MRI in the treatment effect and prognosis evaluation of CNS vasculitis. Material and methods During the follow-up of...
- 18 November 2020
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1118) , 20200743
Comparison of time-of-flight MR angiography and intracranial vessel wall MRI for luminal measurements relative to CT angiography
Objective: To assess whether intracranial vessel wall (IVW) MRI luminal measurements are more accurate than non-contrast 3D-TOF-MRA measurements for intracranial atherosclerotic stenosis, relative to CTA. Methods: Consecutive patients with non-calcified intracranial atherosclerotic stenosis seen on CTA, who had non-contrast 3D-TOF-MRA and IVW performed between 1 January 2013 and 20 April 2014 were selected, and images with stenosis were pre-selected by a single independent rater. The pre-selected CTA, MRA, and IVW (T 1-weighted) images were then reviewed by two independent raters blinded to the other measurements in random order. Measurements were made in a plane perpendicular to the lumen on each modality. MRA and IVW measurements were compared to CTA, to determine which more accurately matched the degree of stenosis. Results: 18 patients with 33 intracranial atherosclerotic stenoses were included. Relative to CTA, IVW had 40% less variance than MRA (p = .004). IVW had a significantly higher concordance correlation coefficient (CCC) relative to CTA than MRA (.87 vs .68, p = .002). IVW and MRA did not have significant bias relative to CTA, however, 8/33 lesions showed >20% overestimation of the degree of stenosis on MRA, compared to 1/33 for IVW. CCC between raters were 0.84 (95% CI 0.67–0.93) for CTA, 0.83 (0.67–0.93) for TOF-MRA, and 0.85 (0.71–0.94) for IVW. For stenosis >50% sensitivity was 82% for IVW and 64% for MRA, while specificity was 73% for both. Conclusion: IVW provides more accurate stenosis measurements than MRA when compared to CTA. Advances in knowledge: Considering higher stenosis measurement accuracy of IVW, it can be more reliably used for quantitative evaluation relative to MRA.
- 18 November 2020
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1118) , 20200743
Comparison of time-of-flight MR angiography and intracranial vessel wall MRI for luminal measurements relative to CT angiography
Objective: To assess whether intracranial vessel wall (IVW) MRI luminal measurements are more accurate than non-contrast 3D-TOF-MRA measurements for intracranial atherosclerotic stenosis, relative to CTA. Methods: Consecutive patients with non-calcified intracranial atherosclerotic stenosis seen on CTA, who had non-contrast 3D-TOF-MRA and IVW performed between 1 January 2013 and 20 April 2014 were selected, and images with stenosis were pre-selected by a single independent rater. The pre-selected CTA, MRA, and IVW (T 1-weighted) images were then reviewed by two independent raters blinded to the other measurements in random order. Measurements were made in a plane perpendicular to the lumen on each modality. MRA and IVW measurements were compared to CTA, to determine which more accurately matched the degree of stenosis. Results: 18 patients with 33 intracranial atherosclerotic stenoses were included. Relative to CTA, IVW had 40% less variance than MRA (p = .004). IVW had a significantly higher concordance correlation coefficient (CCC) relative to CTA than MRA (.87 vs .68, p = .002). IVW and MRA did not have significant bias relative to CTA, however, 8/33 lesions showed >20% overestimation of the degree of stenosis on MRA, compared to 1/33 for IVW. CCC between raters were 0.84 (95% CI 0.67–0.93) for CTA, 0.83 (0.67–0.93) for TOF-MRA, and 0.85 (0.71–0.94) for IVW. For stenosis >50% sensitivity was 82% for IVW and 64% for MRA, while specificity was 73% for both. Conclusion: IVW provides more accurate stenosis measurements than MRA when compared to CTA. Advances in knowledge: Considering higher stenosis measurement accuracy of IVW, it can be more reliably used for quantitative evaluation relative to MRA.